Previous Page  1171 / 1816 Next Page
Information
Show Menu
Previous Page 1171 / 1816 Next Page
Page Background

Recommendations endocrine therapy

Premenopausal

women

5 years of tamoxifen +/- ovarian suppression

Caution against longer durations of treatment when neither safety nor efficacy

data were available.

Soft and Text trial

Additional benefit of ovarian suppression?

Two important questions

•Tamoxifen + Ovarian suppression vs. Aromatase inhibitor + Ovarian

suppression ?

• Tamoxifen + Ovarian suppression vs Tamoxifen

19-9-2017

ASCO guideline